PARK, Byungsoon – Trademark Portfolio
Entity Type: 01
PARK, Byungsoon holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 3 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 4 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include NGAL, IMMUSOME, and DR. PARKCELL. The owner is based in Seoul.
151 Apgujeong-ro, Gangnam-gu
108-202 (Apgujeong-dong, Hyundai Apt.)
Seoul 06001 , KR
Showing of trademarks Trademarks
Trademark Classifications
PARK, Byungsoon's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does PARK, Byungsoon have?
PARK, Byungsoon has 6 U.S. trademarks filed with the USPTO. Of these, 6 registered.
What trademark classes does PARK, Byungsoon file in?
PARK, Byungsoon files trademarks across 4 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 10 (Medical Apparatus), Class 44 (Medical Services), Class 5 (Pharmaceuticals). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.
What are PARK, Byungsoon's most well-known trademarks?
PARK, Byungsoon's registered trademark portfolio includes well-known marks such as NGAL, IMMUSOME, and DR. PARKCELL. These are among 6 currently registered trademarks in the portfolio.
What is PARK, Byungsoon's trademark registration success rate?
PARK, Byungsoon has a 100% trademark registration rate, with 6 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.